Sector: Pharmaceuticals & Biotechnology

Small Cap

Parmax Pharma Share Price

Q: What is the Market Capitalization of Parmax Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Parmax Pharma Ltd. is approximately ₹ 17.1 Cr.

Q: What are the PE and PB ratios for Parmax Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Parmax Pharma Ltd. is -4.1, and the Price-to-Book (PB) ratio is -2.7.

Q: What is the 52-Week High and Low for Parmax Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Parmax Pharma Ltd. shares was ₹ 53.38, and the lowest price was ₹ 22.6.

Q: Who are the major shareholders of Parmax Pharma Ltd.?

Significant shareholdings in Parmax Pharma Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Parmax Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Parmax Pharma Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Parmax Pharma Ltd.

₹46.38

-4.68(-9.17%)

Trade Now

5th Jun 2026 | 3:26 PM

NSE :

Open Free Demat Account

Parmax Pharma Performance

Price Movement

N/A

₹45.00

₹52.50

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹52.50

Low₹45.00

Open at₹52.50

Prev Close₹51.06

Volumes8.44 K

Avg Price₹47.52

Lower Circuit₹36.59

Upper Circuit₹54.87

Historical Performance

3M High₹53.38

3M Low₹22.60

1 Yr High₹53.38

1 Yr Low₹22.60

3 Yr High₹55.02

3 Yr Low₹22.60

5 Yr High₹81.90

5 Yr Low₹22.60

Parmax Pharma Fundamentals

Market Cap

Low in industry

17.10 Cr.

PE Ratio (TTM)

Negative PE TTM

-4.10

Dividend Yield

Net Profit TTM

99% decr over last year

-4.16

Net Profit Growth

99% decr over last year

-4.16

PEG Ratio

Below industry Median

ROE

Operating Revenue TTM

12.11

Operating Revenue Growth

57% decr over last year

Book Value

Negative Price to Book

-2.70

MFI

MFI strongly Overbought

92.99

RSI

RSI is mid-range

66.38

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

-2.70

Parmax Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	3.31	4.33	2.53	1.94	4.83
Operating Expense	4.86	4.52	4.12	2.19	5.39
Operating Profit	-1.55	-0.20	-1.59	-0.25	-0.57
Depreciation	0.25	0.27	0.26	0.24	-0.18
Interest	0.50	0.28	0.24	0.28	0.24
Tax	-1.69	0	0	0	-0.30
Net Profit	-0.58	-0.73	-2.08	-0.76	-1.49

Parmax Pharma Technicals

Parmax Pharma Ltd. EMA & SMA

₹46.38

-4.68 (-9.17%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹44.7

Day EMA10 ₹41.7

Day EMA12 ₹40.8

Day EMA20 ₹38.3

Day EMA26 ₹37.1

Day EMA50 ₹34.7

Day EMA100 ₹33.5

Day EMA200 ₹34.1

Parmax Pharma Support and Resistance

Resistance

First Resistance₹50.49

Second Resistance₹55.24

Third Resistance₹57.99

Support

First Support₹42.99

Second Support₹40.24

Third Support₹35.49

Technical Indicators

Day RSI66.38

Day MFI92.99

Day ADX35.81

Day Commodity Channel Index175.30

William-34.18

Day MACD3.67

Day MACD Signal Line2.36

Day ATR3.79

Day ROC12547.04

Day ROC2142.91

Parmax Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	30.8	30.8	30.8	30.8	30.8	30.8
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	69.2	69.2	69.2	69.2	69.2	69.2

Parmax Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	37.83 K	76.74 K	49.29%
Week	13.71 K	23.58 K	58.15%
1 Month	5.04 K	7.87 K	64.07%
6 Month	1.6 K	2.38 K	67.12%

Parmax Pharma SWOT Analysis

Strengths20

Weakness8

Opportunity0

Threats0

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Results in the last two days with YoY and QoQ Net Profit Growth

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Increasing profits every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

Biggest Price Gainers from Open

Stocks Outperforming their Industry Price Change in the Quarter

Parmax Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Parmax Pharma Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹44	₹550.55	₹216.05	₹268.50	₹41.43	₹6.36
% Change	2.42%	0.29%	-1.84%	0.00%	-1.99%	-1.09%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	15.30	-	14.60	38.40	-98.10	-1.50
1 Year Return		39.08			820.67	539
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 229.65

+2.00%

AMANTA

Amanta Healthcare Ltd.

₹ 134.70

+1.84%

AHCL

Anlon Healthcare Ltd.

₹ 13.98

-1.06%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 84.00

-2.33%

APL

Asston Pharmaceuticals Ltd.

₹ 70.00

-4.12%

WANBURY

Wanbury Ltd.

₹ 265.00

+1.03%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 850.00

+0.68%

KABRADG

Kabra Drugs Ltd.

₹ 22.99

+2.22%

GUJTERC

Gujarat Terce Laboratories Ltd.

₹ 35.95

+2.01%

KOPRAN

Kopran Ltd.

₹ 187.10

-1.05%

LACTOSE

Lactose (India) Ltd.

₹ 109.00

+0.51%

IOLCP

IOL Chemicals and Pharmaceuticals Ltd.

₹ 131.85

+0.13%

ALBERTDAVD

Albert David Ltd.

₹ 717.00

+0.88%

PHRMASI

Phaarmasia Ltd.

₹ 83.50

+0.00%

VIVOBIOT

Vivo Bio Tech Ltd.

₹ 24.48

+0.12%

GUFICBIO

Gufic BioSciences Ltd.

₹ 372.30

+0.64%

JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd.

₹ 202.01

-0.51%

FERMENTA

Fermenta Biotech Ltd.

₹ 338.00

+0.33%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 437.65

-0.16%

PARNAXLAB

Parnax Lab Ltd.

₹ 127.65

-0.27%

NOVARTIND

Novartis India Ltd.

₹ 1392.75

+0.28%

AMBALALSA

Ambalal Sarabhai Enterprises Ltd.

₹ 34.00

-1.36%

FAQ's on PARMAX

What is the Market Capitalization of Parmax Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Parmax Pharma Ltd. is approximately ₹ 17.1 Cr.

What are the PE and PB ratios for Parmax Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Parmax Pharma Ltd. is -4.1, and the Price-to-Book (PB) ratio is -2.7.

What is the 52-Week High and Low for Parmax Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Parmax Pharma Ltd. shares was ₹ 53.38, and the lowest price was ₹ 22.6.

Who are the major shareholders of Parmax Pharma Ltd.?

Significant shareholdings in Parmax Pharma Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Parmax Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Parmax Pharma Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy